Market Tracker

07/31 10:01pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

21.21
Delayed Data
As of Jul 31
 +0.81 / +3.97%
Today’s Change
7.31
Today|||52-Week Range
21.54
+155.54%
Year-to-Date

Today’s Trading

Previous close20.40
Today’s open20.52
Day’s range20.36 - 21.54
Volume747,231
Average volume (3 months)1,147,625
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-51.56%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+915.43%
P/E ratio30.1
Price/Sales3.44
Price/Book12.76

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.89+4.26%
ZFGNZafgen Inc+2.22+6.21%
FLMLFlamel Technologies ...+0.04+0.17%
ACHNAchillion Pharmaceut...+0.13+1.55%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)$0.02
Annual revenue (last year)$122.0M
Annual profit (last year)$19.9M
Net profit margin16.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts